Xeroderma pigmentosum: Living in the dark but with hope in therapy

Drugs of the Future

Volumn 34, Issue 8, 2009, Pages 665-672

  Lima Bessa, K M ^a   Soltys, D J ^a   Marchetto, M C ^b   Menck, C F Martins ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYCLOBUTANE PYRIMIDINE DIMER PHOTOLYASE; DEOXYRIBONUCLEASE (PYRIMIDINE DIMER); IMIQUIMOD; ISOTRETINOIN; KALININ; LENTIVIRUS VECTOR; MEGANUCLEASE; NUCLEASE; PARVOVIRUS VECTOR; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RETINOID; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

CELL THERAPY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CLINICAL TRIAL; DNA REPAIR; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; EPIDERMOLYSIS BULLOSA; EXCISION REPAIR; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN GENOME; IMMUNOGENICITY; MOLECULAR MECHANICS; NONHUMAN; PHOTOSENSITIVITY; QUALITY OF LIFE; RADIATION EXPOSURE; REVIEW; SKIN CANCER; SKIN MANIFESTATION; STEM CELL TRANSPLANTATION; SUNLIGHT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; XERODERMA PIGMENTOSUM;

EID: 84930539170     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2009.034.08.1394556     Document Type: Review

References (59)

1. Schuch, A.P., da Silva Galhardo, R., de Lima-Bessa, K.M., Schuch, N.J., Menck, C.F. Development of a DNA-dosimeter system for monitoring the effects of solar-ultraviolet radiation.Photochem Photobiol Sci 2009, 8(1): 111-20.
2. Costa, R.M., Chigancas, V., da Silva Galhardo, R., Carvalho, H., Menck, C.F. The eukaryotic nucleotide excision repair pathway.Biochimie 2003, 85(11): 1083-99.
3. Nouspikel, T. DNA repair in mammalian cells: Nucleotide excision repair: Variations on versatility.Cell Mol Life Sci 2009, 66(6): 994-1009.
4. Cleaver, J.E. Defective repair replication of DNA in xeroderma pigmentosum.Nature 1968, 218(5142): 652-6.
5. Masutani, C., Kusumoto, R., Yamada, A. et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta.Nature 1999, 399(6737): 700-4.
6. Moriwaki, S., Kraemer, K.H. Xeroderma pigmentosum - Bridging a gap between clinic and laboratory.Photodermatol Photoimmunol Photomed 2001, 17(2): 47-54.
7. Takebe, H., Nishigori, C., Satoh, Y. Genetics and skin cancer of xeroderma pigmentosum in Japan.Jpn J Cancer Res 1987, 78(11): 1135-43.
8. Hengge, U.R., Emmert, S. Clinical features of xeroderma pigmentosum. Adv Exp Med Biol 2008, 637: 10-8.
9. Cleaver, J.E. Common pathways for ultroviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum.J Dermatol Sci 2000, 23(1): 1-11.
10. Kraemer, K.H., DiGiovanna, J.J., Moshell, A.N., Tarone, R.E., Peck, G.L. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin.N Engl J Med 1988, 318(25): 1633-7.
11. Weisberg, N.K., Varghese, M. Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream.Dermatol Surg 2002, 28(6): 518-23.
12. Malhotra, A.K., Gupta, S., Khaitan, B.K., Verma, K.K. Multiple basal cell carcinomas in xeroderma pigmentosum treated with imlquimod 5% cream.Pediatr Dermatol 2008, 25(4): 488-91.
13. Yarosh, D., Klein, J., O'Connor, A., Hawk, J., Rafal, E., Wolf, P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: A randomised study. Xeroderma Pigmentosum Study Group.Lancet 2001, 357(9260): 926-9.
14. Menck, C.F., Armelini, M.G., Lima-Bessa, K.M. On the search for skin gene therapy strategies of xeroderma pigmentosum disease.Curr Gene Ther 2007, 7(3): 163-74.
15. Dormond, E., Perrier, M., Kamen, A. From the first to the third generation adenoviral vector: What parameters are governing the production yield? Biotechnol Adv 2009, 27(2): 133-44.
16. Armelini, M.G., Lima-Bessa, K.M., Marchetto, M.C. et al. Exploring DNA damage responses in human cells with recombinant adenoviral vectors. Hum Exp Toxicol 2007, 26(11): 899-906.
17. Muotri, A.R., Marchetto, M.C., Zerbini, L.F., Libermann, T.A., Ventura, A.M., Sarasin, A., Menck, C.F. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.Hum Gene Ther 2002, 13(15): 1833-44.
18. Armelini, M.G., Muotri, A.R., Marchetto, M.C., de Lima-Bessa, K.M., Sarasin, A., Menck, C.F. Restoring DNA repair capacity of cells from three distinct diseases by XPD gene-recombinant adenovirus.Cancer Gene Ther 2005, 12(4): 389-96.
19. Lima-Bessa, K.M., Chigancas, V., Stary, A. et al. Adenovirus mediated transduction of the human DNA polymerase eta cDNA. DNA Repair (Amst) 2006, 5(8): 925-34.
20. Leite, R.A., Marchetto, M.C., Muotri, A.R., Vasconcelos Dde, M., de Oliveira, Z.N., Machado, M.C., Menck, C.F. Identification of XP complementation groups by recombinant adenovirus carrying DNA repair genes. J Invest Dermatol 2009, 129(2): 502-6.
21. Tanaka, K., Kamiuchi, S., Ren, Y. et al. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency. Mutat Res 2001, 477(1-2): 31-40.
22. Meira, L.B., Reis, A.M., Cheo, D.L., Nahari, D., Burns, D.K., Friedberg, E.C. Cancer predisposition in mutant mice defective in multiple genetic pathways: Uncovering important genetic interactions. Mutat Res 2001, 477(1-2): 51-8.
23. Marchetto, M.C., Muotri, A.R., Burns, D.K., Friedberg, E.C., Menck, C.F. Gene transduction in skin cells: Preventing cancer in xeroderma pigmentosum mice. Proc Natl Acad Sci USA 2004, 101(51): 17759-64.
24. Sakurai, F. Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35. Biol Pharm Bull 2008, 31(10): 1819-25.
25. Croyle, M.A., Cheng, X., Wilson, J.M. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther 2001, 8(17): 1281-90.
26. Ritter, T., Lehmann, M., Volk, H.D. Improvements in gene therapy: Averting the immune response to adenoviral vectors. BioDrugs 2002, 16(1): 3-10.
27. Daya, S., Berns, K.I. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 2008, 21(4): 583-93.
28. Agrawal, N., You, H., Liu, Y. et al. Generation of recombinant skin in vitro by adeno-assodated virus type 2 vector transduction. Tissue Eng 2004, 10(11-12): 1707-15.
29. Muhle, C., Neuner, A., Park, J., Pacho, F., Jiang, Q., Waddington, S.N., Schneider, H. Evaluation of prenatal intro-amniotic LAMB3 gene delivery in a mouse model of Herlitz disease. Gene Ther 2006, 13(23): 1665-76.
30. Hengge, U.R., Mirmohammadsadegh, A. Adeno-assodated virus expresses transgenes in hair follicles and epidermis. Mol Ther 2000, 2(3): 188-94.
31. Pfutzner, W. Retroviral bicistronic vectors. Drug News Perspect 2008, 21(9): 473-80.
32. Zeng, L., Quilliet, X., Chevallier-Lagente, O., Eveno, E., Sarasin, A., Mezzina, M. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C. Gene Ther 1997, 4(10): 1077-84.
33. Arnaudeau-Begard, C., Brellier, F., Chevallier-Lagente, O., Hoeijmakers, J., Bernerd, F., Sarasin, A., Magnaldo, T. Genetic correction of DNA repair-deficient/cancer-prone xeroderma pigmentosum group C kerotinocytes. Hum Gene Ther 2003, 14(10): 983-96.
34. Schambach, A., Baum, C. Clinical application of lentiviral vectors - Concepts and practice. Curr Gene Ther 2008, 8(6): 474-82.
35. Marchetto, M.C., Correa, R.G., Menck, C.F., Muotri, A.R. Functional lentiviral vectors for xeroderma pigmentosum gene therapy. J Biotechnol 2006, 126(4): 424-30.
36. Rezvani, H.R., Ged, C., Bouadjar, B., de Verneuil, H., Taieb, A. Catalase overexpression reduces UVB-induced apoptosis in a human xeroderma pigmentosum reconstructed epidermis. Cancer Gene Ther 2008, 15(4): 241-51.
37. Paques, F., Duchateau, P. Meganucleases and DNA double-strand break-induced recombination: Perspectives for gene therapy. Curr Gene Ther 2007, 7(1): 49-66.
38. Thierry, A., Dujon, B. Nested chromosomal fragmentation in yeast using the meganuclease I-Sce I: A new method for physical mapping of eukaryotic genomes. Nucleic Acids Res 1992, 20(21): 5625-31.
39. Smith, J., Grizot, S., Arnould, S. et al. A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences.Nucleic Acids Res 2006, 34(22): e149.
40. Fajardo-Sanchez, E., Stricher, F., Paques, F., Isalan, M., Serrano, L. Computer design of obligate heterodimer meganucleases allows efficient cutting of custom DNA sequences.Nucleic Acids Res 2008, 36(7): 2163-73.
41. Doyon, J.B., Pattanayak, V., Meyer, C.B., Liu, D.R. Directed evolution and substrate specificity profile of homing endonuclease I-Scel.J Am Chem Soc 2006, 128(7): 2477-84.
42. Sussman, D., Chadsey, M., Fauce, S. et al. Isolation and characterization of new homing endonuclease specificities at individual target site positions. J Mol Biol 2004, 342(1): 31-41.
43. Rosen, L.E., Morrison, H.A., Masri, S. et al. Homing endonuclease I-Crel derivatives with novel DNA target specificities.Nucleic Acids Res 2006, 34(17): 4791-800.
44. Arnould, S., Perez, C., Cabaniols, J.P. et al. Engineered I-Crel derivatives cleaving sequences from the human XPC gene can induce highly efficient gene correction in mammalian cells.J Mol Biol 2007, 371(1): 49-65.
45. Redondo, P., Prieto, J., Munoz, I.G. et al. Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. Nature 2008, 456(7218): 107-11.
46. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., Jones, J.M. Embryonic stem cell lines derived from human blastocysts.Science 1998, 282(5391): 1145-7.
47. Thomson, J.A., Odorico, J.S. Human embryonic stem cell and embryonic germ cell lines.Trends Biotechnol 2000, 18(2): 53-7.
48. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell 2007, 131(5): 861-72.
49. Ji, L., Allen-Hoffmann, B.L., de Pablo, J.J., Palecek, S.P. Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors.Tissue Eng 2006, 12(4): 665-79.
50. Hewitt, K.J., Shamis, Y., Carlson, M.W., Aberdam, E., Aberdam, D., Garlick, J. Three-dimensional epithelial tissues generated from human embryonic stem cells.Tissue Eng Part A 2009, Epub ahead of print.
51. Gallico, G.G. 3rd, O'Connor, N.E., Compton, C.C., Kehinde, O., Green, H. Permanent coverage of large burn wounds with autologous cultured human epithdium.N Engl J Med 1984, 311(7): 448-51.
52. Pellegrini, G., Ranno, R., Stracuzzi, G. et al. The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin.Transplantation 1999, 68(6): 868-79.
53. Ronfard, V., Rives, J.M., Neveux, Y., Carsin, H., Barrandon, Y. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix.Transplantation 2000, 70(11): 1588-98.
54. Gibbs, S., van den Hoogenband, H.M., Kirtschig, G. et al. Autologous full-thickness skin substitute for healing chronic wounds.Br J Dermatol 2006, 155(2): 267-74.
55. Schurr, M.J., Foster, K.N., Centanni, J.M. et al. Phase I/II clinical evaluation of StrataGraft: A consistent, pathogen-free human skin substitute. J Trauma 2009, 66(3): 866-73; discussion 73-4.
56. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I.I., Thomson, J.A. Human induced pluripotent stem cells free of vector and transgene sequences.Science 2009, 324(5928): 797-801.
57. Zhou, H., Wu, S., Joo, J.Y. et al. Generation of induced pluripotent stem cells using recombinant proteins.Cell Stem Cell 2009, 4(5): 381-4.
58. Mavilio, F., Pellegrini, G., Ferrari, S. et al. Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.Nat Med 2006, 12(12): 1397-402.
59. Bergoglio, V., Larcher, F., Chevallier-Lagente, O. et al. Safe selection of genetically manipulated human primary keratinocytes with very high growth potential using CD24.Mol Ther 2007, 15(12): 2186-93.